Skip to content

Safe Indoor Temperature Limit for Fans

Fan Use During Extreme Heat: Safe Thermal Limits

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06584903
Enrollment
10
Registered
2024-09-05
Start date
2024-01-20
Completion date
2024-04-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fans, Healthy, Heat Exposure, Young Adults

Keywords

indoor temperature, core temperature, heart rate, electric fans, cardiovascular strain

Brief summary

Extreme heat events are a significant global threat to health and wellbeing, and result in more morbidity and mortality than all other natural disasters combined. Thus, a key priority is identifying effective and accessible heat resilience solutions to protect individuals from the potentially fatal consequences of heat stress. Within a range of ambient conditions, a fan has been recognized a low-cost heat resilience solution. However, when ambient temperatures exceed skin temperatures (e.g., above 35°C), a fan will incur greater dry heat gain which may be counterbalanced with evaporation of sweat from the skin surface. However, at a critical indoor temperature, the rate of heat gain will exceed the rate of evaporation resulting in net heat gain. The critical indoor temperature has yet to be determined. The purpose of this present study is to identify the indoor temperature at which a fan results in greater cardiovascular and thermal strain relative to still air in young adults using a simulated heat wave scenario of a warming room.

Interventions

OTHERTemperature Ramp Protocol

Following a 45 minute baseline in 37°C seated on a chair, the indoor temperature in the climate-controlled room increased from 37°C to 47°C at \ 0.06°C/min (relative humidity \ 26%) over 180 minutes.

Sponsors

Lakehead University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index less than 30 * male or female * ability to tolerate hot environments for a prolonged period (e.g. >2 h)

Exclusion criteria

* Any respiratory disease * Any cardiovascular disease, including hypertension * Diabetes * not currently on any medication (except oral contraceptives)

Design outcomes

Primary

MeasureTime frameDescription
Whole-Body Sweat RateAt baseline (e.g. 0 minutes), and every minute for the 180 minute experimental trialNet difference in body mass (pre versus post) using a balance scale placed below the chair of the participant
Skin TemperatureAt baseline (e.g. 0 minutes), and every minute for the 180 minute experimental trialMeasured at 4 skin locations (chest, arm, thigh, and calf) using wireless iButtons affixed to the skin with surgical tape
Core TemperatureAt baseline (e.g. 0 minutes), and every minute for the 180 minute experimental trialrectal temperature measured with a pediatric grade thermistor probe
Blood PressureAt baseline (e.g. 0 minutes), and every 10 minutes of exposure up to 180 minutesMeasured with an electrocardiogram-gated automated cuff
Rate Pressure ProductAt baseline (e.g. 0 minutes), and every 10 minutes of exposure up to 180 minutes
Heart RateAt baseline (e.g. 0 minutes), and every minute for the 180 minute experimental trialMeasured with a 3-lead electrocardiogram

Secondary

MeasureTime frameDescription
Thermal comfortAssessed at baseline (e.g. 0 minutes), and every 10 minutes for the 180 minute experimental trialvisual analog scale
Thermal SensationAt baseline (e.g. 0 minutes), and every 10 minutes for the 180 minute experimental trialvisual analog scale

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026